Niagen Bioscience NAGE Cash Flow Statement (2010-2026)

NASDAQ NAGE
$2.19 -0.09 (-3.73%)
As of: Nov 10, 2026 · 10:12 AM EST
Reported Financials

Niagen Bioscience Quarterly Cash Flow Statement

Periods 62 quarters
Latest Sep 2026

Niagen Bioscience reported cash from operations of $2.62M and free cash flow of $2.57M for the quarter ended Sep 2026, down 28.9% year over year. This cash flow statement covers 62 quarters of results from Oct 2010 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
-5.33M-7.74M-6.40M-0.99M-1.42M-1.90M-2.19M-0.96M0.11M-0.49M-0.02M1.88M7.18M5.06M3.61M4.58M4.08M6.32M0.96M-1.17M
Depreciation and DepletionDep. & Depletion
0.21M0.20M0.21M0.24M0.22M0.23M0.23M0.23M0.18M0.18M0.17M0.16M0.15M0.16M0.16M0.16M0.14M0.12M0.12M0.12M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
0.05M0.05M0.05M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.04M0.06M0.18M0.17M0.18M
Amortization of Deferred ChargesAmort. Deferred Charges
Depreciation & Amortization (CF)Dep. & Amort.
0.21M0.20M0.21M0.24M0.22M0.23M0.23M0.23M0.18M0.18M0.17M0.16M0.15M0.16M0.16M0.16M0.14M0.12M0.12M0.12M
Share-based CompensationStock Comp.
1.47M1.89M1.30M1.23M1.33M1.27M1.32M1.12M1.04M0.98M1.19M0.74M0.75M1.08M1.49M1.76M1.75M1.72M1.72M1.52M
Gains from Sales and DivestituresGains Divest
0.02M0.00M0.02M0.00M4.80M0.00M
Other non-cash itemsOther Non-Cash
0.35M0.33M0.18M0.21M0.24M0.51M0.40M0.20M0.19M0.23M0.20M0.20M-1.13M-1.14M0.26M0.17M0.25M0.38M0.24M0.32M
Change in Working Capital
Change in ReceivablesChange Receivables
Change in InventoryChange Inventory
0.93M1.71M0.45M-0.12M-0.96M-2.77M0.07M0.65M1.90M-2.03M-0.98M-0.97M-1.35M1.99M3.22M4.39M2.04M3.57M-3.38M-0.12M
Change in Account PayablesChange Payables
-0.38M-0.64M0.42M-1.08M0.56M-0.73M1.08M-0.83M1.03M-2.33M0.21M-1.20M2.26M2.11M3.05M-0.94M-1.95M2.48M-3.84M2.06M
Change in Accrued ExpensesChange Accrued Exp.
0.15M1.65M-1.43M0.06M0.58M1.27M-0.53M1.11M0.30M0.97M-1.84M0.97M1.11M1.23M-1.67M1.32M0.96M-0.10M-3.78M0.09M
Change in Other Operating AssetsOther Assets Change
0.46M1.16M-2.46M3.39M2.41M0.50M-3.04M-0.07M-0.21M1.30M1.01M-0.70M-0.20M-1.99M2.43M-1.25M0.52M3.61M-4.20M-0.11M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.08M-0.06M-0.20M-0.17M-0.43M-0.18M-0.27M-0.12M-0.56M-0.01M-0.17M-0.93M0.19M-0.66M-0.04M-0.25M-0.13M-0.32M-0.43M-0.72M
Other Working Capital ChangesOther WC Changes
-0.54M-1.22M2.26M-3.56M-2.84M-0.67M2.77M-0.05M-0.35M-1.31M-1.18M-0.23M0.39M1.34M-2.46M1.00M-0.65M-3.93M3.77M-0.61M
Cash from OperationsCash from Ops.
-4.94M-7.20M-3.83M-3.74M-0.33M2.79M3.28M0.40M0.65M0.30M-0.26M3.50M8.58M7.88M1.25M3.69M0.68M-1.19M2.77M2.63M
Investing Activities
Capital ExpendituresCapex
0.00M0.03M0.09M0.05M0.17M0.09M0.01M0.03M0.02M0.04M0.01M0.04M0.07M0.03M0.14M0.02M0.10M0.06M0.09M0.05M
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
0.00M-0.03M-0.09M-0.05M-0.17M-0.09M-0.01M-0.03M-0.02M-0.04M-0.01M-0.04M-0.07M-0.03M-0.14M-0.02M-0.10M-0.06M-0.09M-0.05M
Change in IntangiblesChange Intangibless
Divestments
5.80M
Net of Acquisitions & DivestmentsNet Acquisitions
5.80M
Purchase of InvestmentsInvestments Purchased
Cash from Investing ActivitiesCash from Investing
0.00M-0.03M-0.09M-0.05M-0.17M-0.09M-0.01M-0.03M-0.02M-0.04M-0.01M-0.02M-0.07M-0.03M-0.14M-0.02M-0.10M5.25M-0.09M-0.05M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
0.00M0.00M0.00M0.00M0.01M0.00M0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.00M0.00M0.00M0.00M-0.01M0.00M-0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.00M0.00M0.00M0.00M-0.01M0.00M-0.01M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.13M7.75M0.60M1.04M3.79M3.11M3.75M0.15M0.23M0.11M0.31M0.49M
Shares Repurchased
2.35M2.77M
Net Shares Issued and RepurchasedNet Shares Issued
0.13M7.75M0.60M1.04M3.79M3.11M3.75M0.15M0.23M-2.24M-2.46M0.49M
Net Equity Issued and RepurchasedNet Equity Issued
0.13M7.75M0.60M1.04M3.79M3.11M3.75M0.15M0.23M-2.24M-2.46M0.49M
Other financing activities (as filed)
-0.06M-0.02M-0.06M-0.08M-0.01M-0.04M-0.01M-0.01M-0.06M-0.05M
Cash from Financing ActivitiesCash from Financing
0.06M0.00M0.00M-0.02M7.68M0.00M-0.01M0.00M-0.08M-0.01M0.60M1.04M3.75M3.11M3.74M0.15M-0.08M-2.29M-2.49M0.20M
Additional items
Change in Cash
-4.88M-7.23M-3.92M-3.81M7.18M2.70M3.27M0.37M0.55M0.24M0.32M4.51M12.26M10.96M4.86M3.82M0.50M1.76M0.19M2.77M
Ending Cash Balance
28.22M20.99M17.07M13.26M20.44M23.14M26.41M26.77M27.33M27.57M27.89M32.40M44.66M55.62M60.47M64.29M64.79M66.55M66.74M69.51M
Free Cash FlowFCF
-4.95M-7.22M-3.92M-3.79M-0.50M2.70M3.27M0.37M0.63M0.25M-0.28M3.45M8.51M7.85M1.12M3.67M0.58M-1.26M2.68M2.57M
Net Cash FlowNCF
-4.88M-7.23M-3.92M-3.81M7.18M2.70M3.27M0.37M0.55M0.24M0.32M4.51M12.26M10.96M4.86M3.82M0.50M1.76M0.19M2.77M
Interest Paid

Niagen Bioscience Cash Flow Statement API

Pull Niagen Bioscience's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=NAGE&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY